Avidity Biosciences, Inc.
RNA
$26.57
-$1.53-5.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -51.87% | -38.69% | -30.47% | -19.01% | -21.97% |
| Total Depreciation and Amortization | 32.13% | 42.10% | 50.15% | 60.59% | 51.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.98% | 10.62% | 8.46% | 2.68% | 2.23% |
| Change in Net Operating Assets | -123.81% | 1,591.69% | 880.23% | 946.42% | 764.99% |
| Cash from Operations | -152.70% | -5.58% | 8.39% | 9.75% | 12.63% |
| Capital Expenditure | -67.12% | 4.79% | -1.48% | 14.47% | -49.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -573.17% | -298.01% | -98.78% | 117.54% | 32.75% |
| Cash from Investing | -556.72% | -291.25% | -96.67% | 115.64% | 31.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,019.66% | 249.81% | 110.51% | -7.60% | -72.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,170.30% | 296.08% | 151.47% | 33.43% | -72.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.01% | 594.85% | 1,372.59% | 1,795.67% | -878.37% |
